The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Parra, Eliane Soler ^a   Panzoldo, Natália Baratella ^a   Kaplan, Denise ^a   De Oliveira, Helena Coutinho Franco ^a   Dos Santos, José Ernesto ^b   De Carvalho, Luiz Sérgio Fernandes ^a   Sposito, Andrei Carvalho ^a   Gidlund, Magnus ^b   Nakamura, Ruy Tsutomu ^a   De Souza Zago, Vanessa Helena ^a   Nakandakare, Edna Regina ^b   Quintão, Eder Carlos Rocha ^b   De Faria, Eliana Cotta ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carotid atherosclerosis; Carotid intima media thickness; Cholesteryl ester transfer protein; Genetic polymorphism

Indexed keywords

C REACTIVE PROTEIN; LIPID; PHOSPHOLIPID TRANSFER PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ATHEROSCLEROSIS; CHEMICAL ANALYSIS; CHOLESTERYL ESTER TRANSFER PROTEIN GENE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DNA POLYMORPHISM; ECHOGRAPHY; FEMALE; GENE; GENOTYPE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RISK ASSESSMENT;

ADULT; AGED; AUTOANTIBODIES; BRAZIL; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENE FREQUENCY; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PHOSPHOLIPID TRANSFER PROTEINS; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84866989143     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-130     Document Type: Article

References (26)

1. Atherosclerosis the road ahead. Glass CK, Witztum JL, Cell 2001 104 503 516 10.1016/S0092-8674(01)00238-0 11239408 (Pubitemid 32201946)
2. A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women. Parra ES, Urban A, Panzoldo NB, Nakamura RT, Oliveira R, De Faria EC, Lipids Health Dis 2011 10 87 10.1186/1476-511X-10-87 21609439
3. The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease. Kolovou G, Vasiliadis I, Kolovou V, Karakosta A, Mavrogeni S, Papadopoulou E, Papamentzelopoulos S, Giannakopoulou V, Marvaki A, Degiannis D, Bilianou H, Lipids Health Dis 2011 10 156 10.1186/1476-511X-10-156 21899732
4. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. Boekholdt SM, Thompson JF, J Lipid Res 2003 44 1080 1093 10.1194/jlr.R200018-JLR200 12639975 (Pubitemid 37279626)
5. Cholesteryl ester transfer protein: the controversial relation to atherosclerosis and emerging new biological roles. Oliveira HC, De Faria EC, IUBMB Life 2011 63 248 257 10.1002/iub.448 21488146
6. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Savolainen MJ, Hannuksela M, Seppanen S, Kervinen K, Kesaniemi YA, Eur J Clin Invest 1990 20 593 599 2127749
7. A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3. Eyre J, Hammett F, Miller NE, Clin Chim Acta 1981 114 225 231 10.1016/0009-8981(81)90395-8 7285347 (Pubitemid 11042527)
8. Determination of the mass concentration and the activity of the plasma cholesteryl ester transfer protein (CETP). Lagrost L, Methods Mol Biol 1998 110 231 241 9918050
9. Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Damen J, Regts J, Scherphof G, Biochim Biophys Acta 1982 712 444 452 10.1016/0005-2760(82)90271-5 7126618 (Pubitemid 13198975)
10. Monoclonal antibodies against low density lipoprotein with various degrees of oxidative modifications. Gidlund M, Damasceno NR, Lindoso JA, Abdalla DS, Goto H, Braz J Med Biol Res 1996 29 1625 1628 9222422 (Pubitemid 126485411)
11. Micrométodo para extraçäo de DNA genômico útil no diagnástico molecular da Hipercolesterolemia Familial. Salazar LA, Melo CE, Cavalli SA, Hinuy HM, Hirata MH, Hirata RDC, Rev bras anal clin 2001 33 111 116
12. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, et al. J Clin Invest 1995 96 1664 1671 10.1172/JCI118207 7657837
13. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesaniemi YA, Tahvanainen E, Humphries S, Eur J Clin Invest 1999 29 116 128 10.1046/j.1365-2362.1999.00412.x 10092998 (Pubitemid 29090250)
14. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Simons PC, Algra A, Bots ML, Grobbee DE, Van der Graaf Y, Circulation 1999 100 951 957 10.1161/01.CIR.100.9.951 10468526 (Pubitemid 29407176)
15. Haploview: analysis and visualization of LD and haplotype maps. Barrett JC, Fry B, Maller J, Daly MJ, Bioinformatics 2005 21 263 265 10.1093/bioinformatics/bth457 15297300 (Pubitemid 40202029)
16. Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study. Elosua R, Cupples LA, Fox CS, Polak JF, D'Agostino RA Sr, Wolf PA, O'Donnell CJ, Ordovas JM, Atherosclerosis 2006 189 222 228 10.1016/j. atherosclerosis.2005.12.005 16430904 (Pubitemid 44468071)
17. Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: Effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis. Soyal SM, Sandhofer A, Hahne P, Oberkofler H, Felder T, Iglseder B, Miller K, Krempler F, Patsch JR, Paulweber B, Patsch W, Atherosclerosis 2011 216 374 380 10.1016/j.atherosclerosis.2011.01.052 21371711
18. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Tsai MY, Johnson C, Kao WH, Sharrett AR, Arends VL, Kronmal R, Jenny NS, Jacobs DR Jr, Arnett D, O' Leary D, Post W, Atherosclerosis 2008 200 359 367 10.1016/j.atherosclerosis.2007.12.038 18243217
19. Human cholesteryl ester transfer protein expression enhances the mouse survival rate in an experimental systemic inflammation model: a novel role for CETP. Cazita PM, Barbeiro DF, Moretti AI, Quintao EC, Soriano FG, Shock 2008 30 590 595 10.1097/SHK.0b013e31816e30fd 18391856
20. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients. Grion CM, Cardoso LT, Perazolo TF, Garcia AS, Barbosa DS, Morimoto HK, Matsuo T, Carrilho AJ, Eur J Clin Invest 2010 40 330 338 10.1111/j.1365-2362.2010.02269.x 20486994
21. Genetic and nongenetic sources of variation in phospholipid transfer protein activity. Jarvik GP, Rajagopalan R, Rosenthal EA, Wolfbauer G, McKinstry L, Vaze A, Brunzell J, Motulsky AG, Nickerson DA, Heagerty PJ, et al. J Lipid Res 2010 51 983 990 10.1194/jlr.M000125 19965587
22. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population. Chen HW, Kuo CL, Huang CS, Kuo SJ, Liu CS, Cardiology 2008 110 252 259 10.1159/000112409 18073481 (Pubitemid 351919792)
23. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ, Arterioscler Thromb Vasc Biol 2005 25 2185 2191 10.1161/01.ATV.0000183727.90611.4f 16123324 (Pubitemid 41416319)
24. Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke. Kim BS, Jung HS, Bang OY, Chung CS, Lee KH, Kim GM, Atherosclerosis 2010 212 682 688 10.1016/j.atherosclerosis.2010.07.007 20691971
25. Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects. Relvas WG, Izar MC, Helfenstein T, Fonseca MI, Colovati M, Oliveira A, Ihara SS, Han SW, Las Casas AA Jr, Fonseca FA, Atherosclerosis 2005 178 101 105 10.1016/j.atherosclerosis. 2004.05.025 15585206 (Pubitemid 39600821)
26. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with CETP concentration. Klerkx AH, Tanck MW, Kastelein JJ, Molhuizen HO, Jukema JW, Zwinderman AH, Kuivenhoven JA, Hum Mol Genet 2003 12 111 123 10.1093/hmg/ddg013 12499392 (Pubitemid 36124447)